BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hadji H, Bouchemal K. Advances in the treatment of inflammatory bowel disease: Focus on polysaccharide nanoparticulate drug delivery systems. Adv Drug Deliv Rev 2022;181:114101. [PMID: 34999122 DOI: 10.1016/j.addr.2021.114101] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Falsafi SR, Bangar SP, Chaudhary V, Hosseini E, Mokhtari Z, Karaca AC, Samota MK, Goswami D, Krishnan V, Askari G, Rostamabadi H. Recent advances in oral delivery of bioactive molecules: Focus on prebiotic carbohydrates as vehicle matrices. Carbohydrate Polymers 2022;298:120074. [DOI: 10.1016/j.carbpol.2022.120074] [Reference Citation Analysis]
2 Stanisz M, Klapiszewski Ł, Moszyński D, Stanisz BJ, Jesionowski T. Evaluation of cilazapril release profiles with the use of lignin-based spherical particles. Journal of Drug Delivery Science and Technology 2022;75:103636. [DOI: 10.1016/j.jddst.2022.103636] [Reference Citation Analysis]
3 Olshannikova SS, Malykhina NV, Lavlinskaya MS, Sorokin AV, Yudin NE, Vyshkvorkina YM, Lukin AN, Holyavka MG, Artyukhov VG. Novel Immobilized Biocatalysts Based on Cysteine Proteases Bound to 2-(4-Acetamido-2-sulfanilamide) Chitosan and Research on Their Structural Features. Polymers (Basel) 2022;14:3223. [PMID: 35956736 DOI: 10.3390/polym14153223] [Reference Citation Analysis]
4 Li DF, Yang MF, Xu HM, Zhu MZ, Zhang Y, Tian CM, Nie YQ, Wang JY, Liang YJ, Yao J, Wang LS. Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease. J Mater Chem B 2022. [PMID: 35876136 DOI: 10.1039/d2tb01190e] [Reference Citation Analysis]
5 Sabater C, Calvete-torre I, Ruiz L, Margolles A. Arabinoxylan and Pectin Metabolism in Crohn’s Disease Microbiota: An In Silico Study. IJMS 2022;23:7093. [DOI: 10.3390/ijms23137093] [Reference Citation Analysis]